» Articles » PMID: 26743090

Progressive Multifocal Leukoencephalopathy in Primary Immune Deficiencies: Stat1 Gain of Function and Review of the Literature

Abstract

Background: Progressive multifocal leukoencephalopathy (PML) is a rare, severe, otherwise fatal viral infection of the white matter of the brain caused by the polyomavirus JC virus, which typically occurs only in immunocompromised patients. One patient with dominant gain-of-function (GOF) mutation in signal transducer and activator of transcription 1 (STAT1) with chronic mucocutaneous candidiasis and PML was reported previously. We aim to identify the molecular defect in 3 patients with PML and to review the literature on PML in primary immune defects (PIDs).

Methods: STAT1 was sequenced in 3 patients with PML. U3C cell lines were transfected with STAT1 and assays to search for STAT1 phosphorylation, transcriptional response, and target gene expression were performed.

Results: We identified 3 new unrelated cases of PML in patients with GOF STAT1 mutations, including the novel STAT1 mutation, L400Q. These STAT1 mutations caused delayed STAT1 dephosphorylation and enhanced interferon-gamma-driven responses. In our review of the literature regarding PML in primary immune deficiencies we found 26 cases, only 54% of which were molecularly characterized, the remainder being syndromically diagnosed only.

Conclusions: The occurrence of PML in 4 cases of STAT1 GOF suggests that STAT1 plays a critical role in the control of JC virus in the central nervous system.

Citing Articles

Infections in Inborn Errors of STATs.

Wang C, Freeman A Pathogens. 2024; 13(11).

PMID: 39599507 PMC: 11597637. DOI: 10.3390/pathogens13110955.


Polyomavirus Wakes Up and Chooses Neurovirulence.

Butic A, Spencer S, Shaheen S, Lukacher A Viruses. 2023; 15(10).

PMID: 37896889 PMC: 10612099. DOI: 10.3390/v15102112.


Leveraging Systems Immunology to Optimize Diagnosis and Treatment of Inborn Errors of Immunity.

Mauracher A, Henrickson S Front Syst Biol. 2023; 2.

PMID: 37670772 PMC: 10477056. DOI: 10.3389/fsysb.2022.910243.


Progressive Multifocal Leukoencephalopathy: Pathogenesis, Diagnostic Tools, and Potential Biomarkers of Response to Therapy.

Schweitzer F, Laurent S, Cortese I, Fink G, Silling S, Skripuletz T Neurology. 2023; 101(16):700-713.

PMID: 37487750 PMC: 10585672. DOI: 10.1212/WNL.0000000000207622.


Progressive multifocal leukoencephalopathy genetic risk variants for pharmacovigilance of immunosuppressant therapies.

Hatchwell E, Smith 3rd E, Jalilzadeh S, Bruno C, Taoufik Y, Hendel-Chavez H Front Neurol. 2023; 13:1016377.

PMID: 36588876 PMC: 9795231. DOI: 10.3389/fneur.2022.1016377.


References
1.
Day-Williams A, Sun C, Jelcic I, McLaughlin H, Harris T, Martin R . Whole Genome Sequencing Reveals a Chromosome 9p Deletion Causing DOCK8 Deficiency in an Adult Diagnosed with Hyper IgE Syndrome Who Developed Progressive Multifocal Leukoencephalopathy. J Clin Immunol. 2014; 35(1):92-6. PMC: 4306731. DOI: 10.1007/s10875-014-0114-4. View

2.
De-Simone F, Sariyer R, Otalora Y, Yarandi S, Craigie M, Gordon J . IFN-Gamma Inhibits JC Virus Replication in Glial Cells by Suppressing T-Antigen Expression. PLoS One. 2015; 10(6):e0129694. PMC: 4465661. DOI: 10.1371/journal.pone.0129694. View

3.
Ferenczy M, Marshall L, Nelson C, Atwood W, Nath A, Khalili K . Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin Microbiol Rev. 2012; 25(3):471-506. PMC: 3416490. DOI: 10.1128/CMR.05031-11. View

4.
MacKenzie J, Wilson K, Perry J, Gallagher A, Jarrett R . Association between simian virus 40 DNA and lymphoma in the United kingdom. J Natl Cancer Inst. 2003; 95(13):1001-3. DOI: 10.1093/jnci/95.13.1001. View

5.
Romberg N, Morbach H, Lawrence M, Kim S, Kang I, Holland S . Gain-of-function STAT1 mutations are associated with PD-L1 overexpression and a defect in B-cell survival. J Allergy Clin Immunol. 2013; 131(6):1691-3. PMC: 3672340. DOI: 10.1016/j.jaci.2013.01.004. View